medline.ch Onkologie Urologische Tumoren

	Intensive nursing interventions for post-treatment anxiety and depression in bladder cancer: A systematic review and meta-analysis. Support Care Cancer Huang X, Chen R, Guo Z, Song C, Li X. PMID: 41686342 [PubMed - indexed for MEDLINE]
	Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging Donswijk ML, Ettema RH, Wondergem M, Cheung Z, van der Poel HG, Oprea-Lager DE, Vis AN. PMID: 41686217 [PubMed - as supplied by publisher]
	Transcriptome and single-cell RNA sequencing analysis with 101 machine learning combinations and experimental verification reveals the mechanism of action of mannose metabolism in bladder cancer. Front Immunol Li A, Zhao K, Wang T, Shi G. PMID: 41685329 [PubMed - indexed for MEDLINE]
	Prognostic gene screening and experimental validation in renal clear cell carcinoma based on spatial transcriptomics and single-cell sequencing. Front Immunol Fu C, Sun L, Zhou T, Bi Y. PMID: 41685311 [PubMed - indexed for MEDLINE]
	Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a Chip. Int J Mol Sci Lupsa N, Heninger E, Ding AB, Sanchez De Diego C, Vietor K, Reese SR, LeBeau AM, Kosoff D, Beebe DJ, Kerr SC, Lang JM. PMID: 41684004 [PubMed - indexed for MEDLINE]
	Vitamin D-Related Information Exposure, Attitudes, and Practices Among Prostate and Breast Cancer Survivors in Poland: Implications for Patient-Physician Communication. Nutrients Miko, Kaczmarczyk K, Miko. PMID: 41683252 [PubMed - indexed for MEDLINE]
	Intersection of Precision Nutrition and Bladder Cancer: A Narrative State-of-the-Art Review of Potential Applications and Challenges. J Clin Med Koçak T, Özbek YD, Bodur M, Ye, A. PMID: 41682926 [PubMed]
	Prognostic Value of the Lung Immune Prognostic Index (LIPI) in Patients with Renal Cell Carcinoma: A Retrospective Cohort Study. J Clin Med Ünlü B, Demir H, Davarc, Culha Y, Baykara M. PMID: 41682869 [PubMed]
	Perioperative Immune-Checkpoint Inhibition in Renal Cell Carcinoma: Lessons Learned and Future Directions. Cancers (Basel) Adika A, Zibelman M. PMID: 41681998 [PubMed]
	SLPI in Prostate Cancer. Cancers (Basel) Rosini D, Cosi I, De Iaco P, Sebastianelli A, Di Stefano G, Serni S, Nesi G, Notaro R, De Angioletti M. PMID: 41681959 [PubMed]
	Contemporary Preoperative Detection of Extraprostatic Extension in Prostate Cancer. Cancers (Basel) St, Milecki T, Ksepka J, Kujawska A, Hendrysiak J, Cie. PMID: 41681930 [PubMed]
	The Optimal Management of Patients with Prostate Cancer with Oligometastatic Disease and Low Metastatic Burden in the PSMA-PET Era. Cancers (Basel) Bhandari M, Lasko I, Pozin J, Chang M, Chao HH, Henry E, Nickols NG, Ritter T, Salama JK, Solanki AA. PMID: 41681924 [PubMed]
	Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation. Cancers (Basel) Robaczy, Maj M, Kilja, Pastuszek B, Reducha E, Nurkiewicz A, Kilja. PMID: 41681860 [PubMed]
	Comprehensive analysis of the causal risk factor from hypertension associated with prognosis and therapeutic response in renal cell carcinoma by multi-omics analysis and validation. Biol Direct Chen WJ, Liu ZC, Yang W, Zhao WJ, Chen JX, Gan SS, Dong KQ, Lu X, Miao K, Cao J, Pan XW, Luo P, Cui XG. PMID: 41680825 [PubMed - as supplied by publisher]
	[(177)Lu]Lu-PSMA radioligand therapy in systemic therapy-naÃ¯ve metastatic hormone-sensitive prostate cancer patients: a retrospective study. Eur J Nucl Med Mol Imaging Langrate IK, Ofner H, Kretschmer-Chott E, Einspieler H, Kulterer OC, Schmitl S, Nics L, Shariat SF, Hacker M, Rasul S, Kramer G. PMID: 41680477 [PubMed - as supplied by publisher]
	Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis Morgans AK, Wallis CJD, Halabi S, Armstrong AJ, Adorjan P, Ghadessi M, Verholen F, Grimm MO. PMID: 41680329 [PubMed - as supplied by publisher]
	Re: Optimal Duration of Androgen Deprivation Therapy with Definitive Radiotherapy for Localized Prostate Cancer. A Meta-analysis. Eur Urol Viti A, Scuderi S, Briganti A, Gandaglia G, Montorsi F. PMID: 41680056 [PubMed - as supplied by publisher]
	Biochemical Recurrence-Free Survival After Radical Prostatectomy in Patients with High-Risk Prostate Cancer: A Nationwide Study of PSMA PET/CT Versus Conventional Imaging. J Nucl Med Mogensen AW, Torp-Pedersen C, Nørgaard M, Petersen LJ, Østergren PB, Zacho HD. PMID: 41679924 [PubMed - as supplied by publisher]
	Phase 2 Prospective Trial of Retreatment with [(177)Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA. J Nucl Med Nikitas J, Holzgreve A, Juarez J, Kimura K, Lira S, Alam H, Contreras M, Theus L, Nguyen AT, Ells Z, Zhu S, Grogan T, Elashoff DA, Unterrainer LM, Dahlbom M, Allen-Auerbach M, Czernin J, Calais J. PMID: 41679923 [PubMed - as supplied by publisher]
	Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Fizazi K, Attard G, Azad AA, Baciarello G, Beltran H, Bjartell A, Blanchard P, Bossaert F, Castro E, Compérat E, de Bono J, Deschamps A, Efstathiou E, Emmett L, Fanti S, Fonteyne V, González-Del-Alba A, Gravis G, James ND, Kanesvaran R, McDermott RS, Mehra N, Parker C, Renard-Penna RM, Rubin MA, Saad F, Sweeney C, Tilki D, Tombal B, Tree AC, Walz J, Zilli T, Gillessen S, ESMO Guidelines Committee. PMID: 41679466 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 175970

Seite 1 von 8799

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung